Trellus Health Share Discussion Threads

[james188] 12/10/2021 16:37

The fair value figure is for each EKF share (not Trellus), so that is the dividend value to focus on in working out the relevant distribution, rather than the number of Trellus shares granted. So the dividend figure in your example would be £837.40.

[rivaldo] 12/10/2021 16:07

Many thanks for the replies. Pldazzle, I'm still a little unsure TBH. So a practical example....

Say you own 100,000 EKF shares. Then the in-specie distribution according to my tax adviser would be 100,000/16.25 x £0.8374, i.e £5,153.23.....whereas you're saying it would be 100,000 x £0.008374 i.e £837.4, i.e ignoring the one share for every 16.25 held allocation. Correct?

[pldazzle] 11/10/2021 19:17

sharw - No, it's specifically a dividend in specie (see quote above) and taxable as such: it's not treated as, nor deemed to be, a return of capital.

[sharw] 11/10/2021 18:31

But as it was existing as an investment of EKF rather than cash is this regarded as a dividend or as a return of capital for tax purposes?

[pldazzle] 11/10/2021 15:10

rivaldo - No, it's 0.8374p (or to put it another way, £0.008374) per EKF share held. See Note 30 to EKF's 2020 accounts:

"In August 2020 the Company invested $5,000,000 (£3,810,000) for a 31.1% shareholding in Trellus Health Limited, a pioneer in resilience-driven care for people with complex chronic conditions. In December 2020 the Company made a distribution in specie whereby, with the exception of a single “golden” share, the Company’s shareholding in Trellus Health Limited was distributed to ordinary shareholders of the Company at a total value of £3,810,000. The fair value per EKF share was 0.8374p. In view of the acquisition and disposal occurring in the same financial period, the Group has not applied equity accounting to this investment, but instead has valued the dividend at cost."

[rivaldo] 11/10/2021 15:01

It's 2020/21 Tax Return time (yay!). My tax adviser has calculated the Trellus dividend in specie received from EKF as follows for each EKF share : 1 EKF share/16.25 x £0.8374p, i.e roughly 5.15p per EKF share held. Does everyone agree this?

[wan] 23/9/2021 07:56

Good presentation yesterday, reiterating the confidence regarding further contracts/commercialisation and scale-up in the the near-term, and confirmation that Trellus is 'already' in discussions with pharma.

[mikemine1] 22/9/2021 10:09

No surprises. Hitting milestones and further progress expected in the coming months. Well funded and losses very well covered. Difficult to say how well Trellus will do as their offering is pretty unique at the moment. Could easily boom but we need patience right now.

[brummy_git] 22/9/2021 08:04

How are things progressing at Trellus Health?

A pioneering deep science based telemedicine firm, focused initially on treating IBD such as Crohns & colitis?

Find out all the news & commentary here after today's interims.

www.linkedin.com/posts/paul-hill-a5994116_trls-activity-6846335114125864960-nCVi

[wan] 22/9/2021 07:46

Results as expected. The attached commentary however is very optimistic and encouraging regarding scale-up and commercialisation.

From where I am standing based on my own research etc, and indeed the Chairman's Statement, it lends further weight to my view that at least one strategic industry partnership might come sooner than perhaps some think. Especially if you also factor in the potential utility across many chronic conditions, which is something that originally caught my attention.

[brummy_git] 17/9/2021 15:44

Great update interview here on Trellus

Hit the bottom of the 2 'red play' buttons

www.voxmarkets.co.uk/articles/stocks-to-follow-with-justin-waite-and-paul-hill-7c37ed7

[brummy_git] 16/9/2021 08:09

Marvellous new 'white label' & highly scalable contract announced today by Trellus Health with New York healthcare provider Connected Health Medicine.

All the commentary here.

www.linkedin.com/posts/paul-hill-a5994116_trls-activity-6844163621367414784-F_4i

[wan] 09/9/2021 15:13

I note the Results and Presentation date, but most readers (including me) will not be able to access the conference call for the Analysts Briefing, as it is only available to healthcare analysts.

Time will tell what the analysts think, but one might also assume there is more to tell than the maiden interim results alone convey.

[wan] 09/9/2021 08:37

Management of chronic conditions and behavioural health cited as an area of telehealth expansion -

Hospital telehealth leveling off at one-fifth of medical appointments, research finds
Published Sept. 8, 2021

Rebecca Pifer
Reporter

Dive Brief:
The use of telehealth for patient visits seems to have leveled off at 20% or fewer of all appointments, more than a year and a half after COVID-19 first spurred an unprecedented jump in utilization, according to a new survey from KLAS Research and the Center for Connected Medicine.

More than 80% of hospital executive respondents to the survey fielded in May and June this year said one-fifth or fewer of their facility's appointments were being conducted virtually. Of the hospitals and health systems reporting 30% or more of their volume is virtual, many said they expected that percentage to decline over the long term as the pandemic wanes in the U.S.

Despite use of telehealth dwindling from last year's peak, many provider organizations say they're looking to expand their virtual care services to better manage patient populations while keeping costs down. The top three areas for future telehealth expansion cited by survey respondents were chronic care management, behavioral health and urgent care.

Dive Insight:
The pandemic resulted in a historic increase in telehealth use last year, as providers quickly pivoted to handling non-emergent visits virtually to recoup lost in-person volume. According to data from EHR provider Epic, telehealth made up almost 70% of all ambulatory visits by mid-April of 2020. Before the pandemic, they made up fewer than 0.01%.

However, telehealth utilization has oscillated since its peak, generally linked to rising and falling COVID-19 cases, experts say. In 2021, usage has more or less fallen off with the reopening of doctor's offices and hospitals and widespread vaccination efforts, though its unclear how the recent resurgence in cases tied to the highly infectious delta variant may have affected virtual visits.

There's a general consensus in the industry that telehealth utilization will never go back to its low pre-pandemic levels, but market watchers are curious where it will level off. That will have huge repercussions for the sustainability of the recent telehealth boom.

Full story, worth reading -

[wan] 08/9/2021 07:59

Above post edited to include more of the story.

[wan] 08/9/2021 07:28

In broader healthcare news, and as healthcare transitions to a new model of care -

Amazon looks to bring telehealth, in-person care to 20 more cities.
It will soon offer the "full package" of hybrid virtual/in-person care in Philadelphia, Chicago, Dallas and Boston, Insider reports, with more expansion to follow in 2022.

By
Kat Jercich
September 07, 2021

Amazon is reportedly looking to launch its app-based home visits in 20 major U.S. cities through 2022.

According to Insider's Blake Dodge, Amazon Care will bring the "full package" of telehealth and in-person services to Philadelphia, Chicago, Dallas and Boston in 2021, with 16 more to follow the next year.

Amazon representatives told Healthcare IT News after publication that the company does not comment on rumors or speculation.

WHY IT MATTERS

Amazon Care has grown rapidly since it was first offered exclusively to the tech giant's Seattle-based employees in 2019.

This past September, Amazon announced it would allow employees to access the app-based care throughout Washington state. It then made services available to other employers in the state before officially expanding its telehealth option to employers in all 50 states this summer.

But its in-person services, which include follow-up blood draws and exams, have been limited so far to users in D.C. and Baltimore, as well as in Washington state.

Now, reports Dodge, Amazon plans to offer in-person options in Atlanta, Denver, Detroit, Houston, Indianapolis, Kansas City, Los Angeles, Miami, Minneapolis, Nashville, New York, Phoenix, Pittsburgh, San Francisco, San Jose and St. Louis in 2022.

That would bring the total number of cities up to 22, in addition to the entirety of Washington state.

Dodge also notes that Amazon has been attempting to make inroads at health plans, which would open up the service to insured people in addition to employer clients.

THE LARGER TREND

In June, an Amazon exec said it had signed several companies to the company's telehealth service.

At the time, VP Babak Parviz said the company is planning to make the "hybrid" virtual/in-person service available in additional regions "as fast as we can."

Amazon also made waves in July with news of its at-home COVID-19 testing kit, which can be purchased for $39.99.

Full story -

Amazon's healthcare website has been updated accordingly -

Experience a new kind of healthcare
Amazon Care is healthcare built around you, your life, and your schedule.

[wan] 03/9/2021 09:46

I should have highlighted in the above, that Laurie Keefer, PhD. is a
co-founder of Trellus Health.

[wan] 03/9/2021 08:42

Interesting -

Sep 2, 2021
As Telehealth Space Expands, Companies Move to Secure Lab Capabilities

With the COVID-19 pandemic driving new investment and uptake of telemedicine, more providers are looking to offer their patients easy access to lab testing

Full story requires subscription -


In this regard, such capability and capacity is likely be assisted by the relationship with EKF.

[wan] 03/9/2021 08:26

Getting Started with Telehealth: What to Know to Make It Work for You
Blog | August 26, 2021
Jessica Caron, MS
Patient Advocacy Advisor
Trellus Health

While not new to healthcare, COVID-19 has pushed telehealth into widespread practice, which is great news for patients — especially those with gastrointestinal illnesses, like Inflammatory Bowel Disease (IBD) and Inflammatory Bowel Syndrome (IBS). Now, telehealth is more accessible and patient-focused than ever before.

In a recent scientific study, telehealth was shown to reduce the “financial burdens of chronic disease, improve patient quality of life, and lead to improved clinical outcomes” in patients with IBD. Such findings should encourage patients with chronic health conditions and give them confidence to consider telehealth as an option we should all try out.

It may be time to try Telehealth
If you haven’t yet, it may be time to try out telehealth. While it shouldn’t replace all aspects of traditional healthcare, telehealth can greatly improve access, reduce wait times and cost, and can even remove exposure concerns that are front-and-center these days.

Full blog post -

[wan] 26/8/2021 11:54

Update...in answer to my complaint to Barclays Smart Investor, part of which was them not showing the Trellus Health 'Entitlements', they have written to me stating they are currently in the process of setting up a line of stock called Trellus Entitlements to enable them to show these new shares.

Smart Investor now shows such entitlements in your ISA as "This product is no longer eligible in ISA" but provides a link into Corporate Actions, where they are shown, including all of the relevant details etc. with the same situation in the SIPP's.

So, let's also hope that the same will apply to the next value enhancement from EKF's relationship with Mount Sinai Innovation Partners.

[wan] 24/8/2021 08:58

Enrolment of 25 patients does not appear, on the face of it, enough to effectively demonstrate and indeed be persuasive in terms of illustrating the benefits. And arguably on its own, is somewhat underwhelming from a 'partner' looking to advance commercial development of the Trellus Health model for treating IBD, but it's at least a start, which importantly aligns with the admission document.

And in my view, it's also likely to be a strong indicator of why we should expect to see further announcements regarding additional demonstration projects in the near future, which yesterdays announcement also refers to, as did the admission document which highlighted 3 demonstration projects involving several hundreds patients and generating revenue in 2021, and expanding to thousands of patients in 2022 (including in the UK).

[nimbo1] 23/8/2021 22:30

not necessarily - highlights market cap vs the current commercial progress... is a medium-long term one imo!

[mikemine1] 23/8/2021 18:14

So, good news and the share price goes down??????? I've heard of "sell on the news" but this is plain ridiculous.